Top Markets
#1 Cortex Cortex +32.55%
#2 龙虾 (Lobster) 龙虾 (Lobster) +16.86%
#3 Akedo Akedo +12.21%
#4 wojak wojak +11.93%
#5 MarsCoin MarsCoin +11.23%
#6 Pons Pons +10.45%
#7 EXOD EXOD +9.04%
#8 The Black Bull The Black Bull +7.87%
#9 Seeker Seeker +7.61%
#10 Official Trump Official Trump +6.67%
Coin of the day
Cortex Cortex
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Ambrx Biopharma Inc. Ambrx Biopharma Inc.

Ambrx Biopharma Inc.

AMAM
Classificação em ações #6983
Ambrx Biopharma Inc. operates as a clinical-stage biotechnology company focused... Ambrx Biopharma Inc. operates as a clinical-stage biotechnology company focused on the discovery and development of precisely engineered biologic medicines. The firm utilizes its unique expanded genetic code technology platform to create these advanced therapies. Leading its pipeline is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is currently undergoing evaluation in several clinical investigations. These include pivotal Phase 2/3 trials for the treatment of HER2-positive metastatic breast cancer and gastric cancer, alongside studies for other solid tumors. Additionally, Ambrx is progressing two earlier-stage drug candidates: ARX517, an anti-PSMA ADC, which is in a Phase 1 clinical trial for prostate cancer and other solid tumor indications; and ARX305, an anti-CD70 ADC, currently in investigational new drug (IND)-enabling studies for potential applications in renal cell carcinoma and other cancers. The company's portfolio also encompasses multiple immuno-oncology programs. Among these are ARX822, a fab-small molecule bispecific therapeutic in preclinical development for various cancers, and ARX102, an immuno-oncology IL-2 pathway agonist intended to stimulate the patient's immune system by targeting beta and gamma receptors on cytotoxic T cells. Founded in 2003 and headquartered in La Jolla, California, Ambrx Biopharma Inc. has established significant collaborations with various pharmaceutical partners, including Bristol Myers Squibb Company, AbbVie Inc., BeiGene, Sino Biopharmaceutical Co., Ltd., NovoCodex, and Elanco Animal Health.
Preço da ação
$28.00
Última sincronização: 2024-03-06
Valor de mercado
$1.77B
Variação (1 dia)
0.07%
Variação (1 ano)
0.00%
País
US
Negociar Ambrx Biopharma Inc. (AMAM)

Categoria

Healthcare
Histórico de preços das ações de Ambrx Biopharma Inc. (AMAM)
Preço de fecho mais alto: $27.98 em 2024-03-01

Preço de fecho mais baixo: $17.04 em 2021-06-01
Histórico de preços das ações da Ambrx Biopharma Inc. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 106.47%
2023 700.38%
2022 -81.39%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 39.87%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 50.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.21 -12.72%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 475.44%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.74%
CH